226 related articles for article (PubMed ID: 22541245)
21. Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI.
Murphy KR; Dhand R; Trudo F; Uryniak T; Aggarwal A; Eckerwall G
Respir Med; 2015 Feb; 109(2):170-9. PubMed ID: 25596138
[TBL] [Abstract][Full Text] [Related]
22. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
[TBL] [Abstract][Full Text] [Related]
23. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
Vogelmeier C; Naya I; Ekelund J
Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
[TBL] [Abstract][Full Text] [Related]
24. Budesonide/formoterol pressurized metered-dose inhaler: in chronic obstructive pulmonary disease.
Lyseng-Williamson KA
Drugs; 2009 Jul; 69(11):1459-70. PubMed ID: 19634924
[TBL] [Abstract][Full Text] [Related]
25. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S
J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189
[TBL] [Abstract][Full Text] [Related]
26. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
Murphy K; Nelson H; Parasuraman B; Boggs R; Miller C; O'Dowd L
Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051
[TBL] [Abstract][Full Text] [Related]
27. Budesonide/Formoterol pressurized metered-dose inhaler.
Lyseng-Williamson KA; Simpson D
Drugs; 2008; 68(13):1855-64. PubMed ID: 18729536
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
29. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study.
Rabe KF; Atienza T; Magyar P; Larsson P; Jorup C; Lalloo UG
Lancet; 2006 Aug; 368(9537):744-53. PubMed ID: 16935685
[TBL] [Abstract][Full Text] [Related]
30. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler.
Chervinsky P; Baker J; Bensch G; Parasuraman B; Boggs R; Martin P; O'Dowd L
Ann Allergy Asthma Immunol; 2008 Nov; 101(5):463-73. PubMed ID: 19055199
[TBL] [Abstract][Full Text] [Related]
31. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
[TBL] [Abstract][Full Text] [Related]
32. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
Aalbers R
Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
[TBL] [Abstract][Full Text] [Related]
33. Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
Balki A; Balamurugan S; Bardapurkar S; Dalal S; Singh A; Singh BP; Vaidya A; Gogtay JA
Pulm Pharmacol Ther; 2018 Feb; 48():28-36. PubMed ID: 28890299
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS.
Wang C; Yang T; Kang J; Chen R; Zhao L; He H; Assam PN; Su R; Bourne E; Ballal S; DeAngelis K; Dorinsky P
Adv Ther; 2020 Apr; 37(4):1591-1607. PubMed ID: 32152869
[TBL] [Abstract][Full Text] [Related]
35. Once- vs twice-daily budesonide/formoterol in 6- to 15-year-old patients with stable asthma.
Eid NS; Noonan MJ; Chipps B; Parasuraman B; Miller CJ; O'Brien CD
Pediatrics; 2010 Sep; 126(3):e565-75. PubMed ID: 20713475
[TBL] [Abstract][Full Text] [Related]
36. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
Dusser D; Vicaut E; Lefrançois G;
Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
[TBL] [Abstract][Full Text] [Related]
37. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
Hampel FC; Martin P; Mezzanotte WS
J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/formoterol in children with asthma: a superiority and therapeutic equivalence study.
Morice AH; Peterson S; Beckman O; Kukova Z
Pulm Pharmacol Ther; 2008; 21(1):152-9. PubMed ID: 17376722
[TBL] [Abstract][Full Text] [Related]
39. Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial.
Arun JJ; Lodha R; Kabra SK
BMC Pediatr; 2012 Mar; 12():21. PubMed ID: 22394648
[TBL] [Abstract][Full Text] [Related]
40. Bronchodilating effects of a new beclometasone dipropionate plus formoterol fumarate formulation via pressurized metered-dose inhaler in asthmatic children: a double-blind, randomized, cross-over clinical study.
Pohunek P; Varoli G; Reznichenko Y; Mokia-Serbina S; Brzostek J; Kostromina V; Kaladze M; Muraro A; Carzana E; Armani S; Kaczmarek J
Eur J Pediatr; 2021 May; 180(5):1467-1475. PubMed ID: 33404895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
